Latest news
IN8bio data show more than 19.5-month median survival in repeat-dose glioblastoma - Stock TitanStock Titan · Thu, 06 Aug 2026 20:01:00 GMTCullinan to begin potentially registrational acute myeloid leukemia study in Q3 - Stock TitanStock Titan · Thu, 06 Aug 2026 11:00:00 GMTOblenio Doses First Patients in Phase 1a Trial of Trispecific T-Cell Engager LBL-051 - BioPharm InternationalBioPharm International · Tue, 04 Aug 2026 17:05:26 GMTVertex–AbCellera T‑Cell Engager Alliance Might Change The Case For Investing In Vertex Pharmaceuticals (VRTX) - simplywall.stsimplywall.st · Fri, 31 Jul 2026 04:54:33 GMTAbCellera Biologics (ABCL) Is Down 5.9% After Vertex-Backed T-Cell Engager Collaboration Announcement - simplywall.stsimplywall.st · Thu, 30 Jul 2026 17:20:42 GMTVertex Will Fund AbCellera's Autoimmune Therapy Research - Stock TitanStock Titan · Wed, 29 Jul 2026 07:00:00 GMTAbCellera and Vertex launch autoimmune T-cell engager partnership - TipRanksTipRanks · Wed, 29 Jul 2026 07:00:00 GMTFor AML patients with limited options, Cullinan plans a new study - Stock TitanStock Titan · Tue, 28 Jul 2026 07:00:00 GMT